What is Atrial Fibrillation?
Atrial fibrillation (AF) often presents as a rapid and irregular heart rhythm. Patients may not show any physical signs of AF, and may not know they are in AF, until they are examined by a physician. However, some patients do show many symptoms of AF such as fatigue, shortness of breath, dizziness, and chest pain. Most of the time the symptoms should go away on their own. However, if AF persists beyond several days, symptoms generally become less intense. There is a chance that symptoms such as generalized fatigue and a reduced tolerance for physical exertion can remain with AF. Risk factors of AF may include high blood pressure, uncontrolled diabetes, sleep apnea, and obesity.
Treatment for Atrial Fibrillation?
For patients with little or no symptoms while in AF, a treatment strategy called "rate control" may be considered. Therapies for these patients may require blood thinners to reduce the risk of a stroke while in AF. Additional medications (beta blockers or calcium channel blockers) may be required to slow the heart rate to a more normal range.
For patients with symptoms at the onset of AF or while in AF, therapy is primarily guided to keep the patient in normal rhythm by suppressing or eliminating the recurrence of AF. This treatment strategy is termed "rhythm control". Anti-arrhythmic drugs (Flecainide, Propafenone, Sotalol, Dofetilide or Amiodarone) are often prescribed and can be very effective in preventing the recurrence of AF after it converts spontaneously or with an electrical shock conversion to the normal sinus rhythm.
What is Catheter Ablation?
If a patient has tried at least one anti-arrhythmic agent and AF still recurs on maximal medication dosage, a procedure known as catheter ablation is generally offered as an alternative long therapy. This is the current recommendation from multiple cardiology and heart rhythm societies.
Patients with no other structural abnormality of the heart and who also have AF that can convert to normal sinus rhythm spontaneously, are known as "lone paroxysmal AF" or lone PAF. Catheter ablation is most successful in this group and is around 75-80% successful after 2 yrs. AF may progress from sporadic to persistent AF over time and electrical shock conversion may be necessary to restore normal sinus rhythm.
In patients with persistent AF, the success rate with catheter ablation is lower and the degree of success decreases significantly with the duration in AF. Those with long, persistent AF, that has been continuously present for over a year, have the poorest success rate, which is currently around 50%. For patients who are not as ideal for catheter ablation, a more invasive approach with surgery may be considered known as "thorascopic maze" or a "mini-maze" surgery. The surgery is done on the outside of the heart, through multiple small incisional portals on both sides of the chest wall. Success rates may still be limited to around 60% over the long term.
Where does ablation take place?
Most AF results from electrical triggers that come from a region of the heart where the four pulmonary veins attach to the left atrium. The four pulmonary veins take blood away from the lungs and deliver it to the left atrium. The goal of ablation is to completely isolate the electrical signals around the pulmonary vein by stopping the electrical signals just outside the mouth of each vein.
There are two different energy sources that are used to isolate pulmonary veins. Radiofrequency is the traditional energy source. Heat created by an electrical current is applied to the tissue in order to eliminate the heart tissue responsible for causing recurrent atrial fibrillation.
The most recently developed energy source is freezing or "cryo". Cryoballoon ablation utilizes a special catheter with a balloon attached to the tip. This is most effective for patients with the early phase of AF (lone paroxysmal AF) and is the preferred method as a first procedure. The catheter is placed with the balloon at the mouth of each pulmonary vein. Nitrous oxide is then infused into the balloon creating a freezing effect, and as a result, tissue in contact with the balloon is frozen. A more even ablation around the opening of the pulmonary vein is created which isolates the electrical activity in the region responsible for causing AF.
